• About us
• Contact

Advertisement

Organisation › Details

Merck KGaA

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2017, Merck generated sales of €15.3 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. *

 

	Start	1668-01-01 established_pre
	Group	Merck (DE) (Group)
	Industry	pharmaceutical
	Industry 2	reagents (bio/biochemical)
	Person	von Roeder, Helene (Merck (DE) 202403 CFO)
	Region	Darmstadt
	Country	Germany
	Street	250 Frankfurter Str.
	City	64293 Darmstadt
	Tel	+49-6151-72-0
		Address record changed: 2024-01-05
Basic data	Employees	I: 50,001 to 100,0 (2023-12-31)
	Currency	EUR
	Annual sales	20,993,000,000 (sales, net, consolidated (2023) 2023-12-31)
	Profit	2,834,000,000 (2023-12-31)
	Cash	1,982,000,000 (2023-12-31)
		* Document for »About Section«: Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt.
		Record changed: 2024-08-17

Advertisement

More documents for Merck (DE) (Group)

• [1] Merck KGaA. (4/25/24). "Press Release: Merck Invests More Than € 300 Million in New Life Science Research Center in Germany". Darmstadt....
• [2] Merck KGaA. (9/12/23). "Press Release: Merck Appoints Axel Löber as Head of Global Communications and Stakeholder Engagement". Darmstadt....
• [3] Endress+Hauser AG. (1/27/23). "Press Release: Change at the Top of Analytik Jena. Ulrich Krauss Charts New Course; Oliver Klaeffling Set to Become Managing Director"....
• [4] Merck KGaA. (11/21622). "Press Release: Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity". Darmstadt....
• [5] Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai....
• [6] Merck KGaA. (4/29/22). "Press Release: Merck Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China". Darmstadt....
• [7] Merck KGaA. (2/7/22). "Press Release: Merck Announces Organizational Transformation of Life Science Business Sector to Strengthen CDMO Offering and Accelerate Future Growth". Darmstadt....
• [8] Merck KGaA. (9/22/21). "Press Release: Sabia Schwarzer Appointed Head of Group Communications, Brand and Corporate Affairs at Merck". Darmstadt....
• [9] Merck KGaA. (10/8/20). "Press Release: Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant". Darmstadt....
• [10] Merck KGaA. (9/28/20). "Press Release: Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021". Darmstadt....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.